STAT

My work-life balance is tilting toward work. I’m trying to tilt it back

It’s easy to feel guilty if weekends often involve more sunglasses than safety glasses. But taking breaks will make me a better scientist in the long run.

“What’s hot for the weekend?”

For graduate students like me, this is a loaded question.

It’s asking, however friendly the intent, “What will you prioritize this weekend? Churning out data, or working on your tan?”

The bread and butter of biomedical research is publishing research papers to get grants to publish more research papers to get more grants. This means hundreds, if not thousands, of hours of work, of timed experiments that don’t skip weekends, and of model organisms that need to be fed and looked after, even if it’s Friday night.

It’s competitive, meaning 10-

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks